HBIO vs SEER: stock comparison and AI forecast
Harvard Bioscience Inc (HBIO) and Seer, Inc. (SEER) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
HBIO Harvard Bioscience Inc
- Market Cap
- $39M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SEER Seer, Inc.
- Price
- $1.63 -13.3% · 6M
- Market Cap
- $90M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- SEER is 2.3 times larger than HBIO by market capitalization ($90M against $39M).
- HBIO carries 9.28 times debt per unit of equity, against 0.11 times for SEER.
- Both companies share the SEC industry classification Laboratory Analytical Instruments.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | HBIO | SEER |
|---|---|---|
| Market Cap | $39M | $90M |
| P/B Ratio | 5.19x | 0.26x |
| EPS | $-12.94 | – |
| Book Value/Share | $1.63 | $6.23 |
| Revenue/Share | $19.29 | $0.26 |
| FCF/Share | $-0.25 | $-0.80 |
Profitability & Margins
| Metric | HBIO | SEER |
|---|---|---|
| ROE | – | -24.8% |
| ROIC | -0.5% | – |
| Gross Margin | 58.2% | 42.0% |
| Operating Margin | -0.3% | -439.2% |
| Net Margin | – | -529.0% |
| EBT Margin | -12.0% | -421.0% |
| Tax Rate | 1.2% | -0.1% |
Financial Health
| Metric | HBIO | SEER |
|---|---|---|
| Current Ratio | 1.87x | 14.74x |
| Quick Ratio | 0.98x | 14.06x |
| D/E Ratio | 9.28x | 0.11x |
| Financial Leverage | 10.28x | – |
| Interest Coverage | -0.8x | -903.3x |
| Working Capital | $22M | $155M |
Cash Flow
| Metric | HBIO | SEER |
|---|---|---|
| Operating Cash Flow | $650K | -$43M |
| Free Cash Flow | -$1M | -$44M |
| Capital Spending | -$2M | -$850K |
| OCF Growth YoY | -90.2% | – |
| FCF Growth YoY | -123.1% | – |
| FCF/Sales | -1.3% | -311.1% |
| CapEx/Sales | 2.0% | 6.0% |
Operational Efficiency
| Metric | HBIO | SEER |
|---|---|---|
| Asset Turnover | 1.15x | – |
| Receivables Turnover | 6.1x | – |
| Inventory Turnover | 1.6x | 1.0x |
| Fixed Assets Turnover | 16.4x | 1.2x |
| Days Sales Outstanding | 60 days | – |
| Days Inventory | 221 days | 376 days |
| Payables Period | 62 days | – |
| Cash Conversion Cycle | 219 days | – |
Income Statement
| Metric | HBIO | SEER |
|---|---|---|
| Total Revenue | $88M | $14M |
| Operating Income | -$240K | -$71M |
| Net Income | – | -$85M |
| R&D Expense | $9M | $38M |
| SG&A Expense | $40M | $40M |
| Cost of Goods Sold | $37M | $7M |
Dividend & Shareholder Information
| Metric | HBIO | SEER |
|---|---|---|
| Shares Outstanding | 5M | 55M |
HBIO vs SEER: stock comparison and AI forecast
Which is bigger, HBIO or SEER?
SEER is 2.3 times larger than HBIO by market capitalization ($90M against $39M).
Which one does Intratio's AI model rank higher, HBIO or SEER?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.